NCT02834624View on ClinicalTrials.gov

Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

July 31, 2015

Conditions
Respiratory Distress Syndrome
Interventions
DRUG

Poractant alfa

Randomized to receive Curosurf as the surfactant to treat respiratory distress syndrome. Doses 3ml/kg. to be repeated as needed by determination of attending neonatologist.

DRUG

calfactant

Randomized to receive Infasurf as the surfactant to treat respiratory distress syndrome. Doses 3ml/kg. to be repeated as needed by determination of attending neonatologist

Trial Locations (1)

65201

University of Missouri, Women's and Children's Hospital, Columbia

All Listed Sponsors
lead

University of Missouri-Columbia

OTHER

NCT02834624 - Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter